Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy
- Conditions
- HER2-positive Breast CancerCirculating Tumor DNAChemotherapy Effect
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT04276337
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prognostic Perspective of Invasive Hyperemic and Non-Hyperemic Physiologic Indices Measured After Percutaneous Coronary Intervention
Completed
- Conditions
- Ischemic Heart Disease
- Interventions
- Device: Percutaneous coronary intervention
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 588
- Registration Number
- NCT04265443
- Locations
- 🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Korea, Republic of
🇰🇷Ulsan Medical Center, Ulsan, Korea, Republic of
🇰🇷Sejong General Hospital, Bucheon, Korea, Republic of
Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease
Not Applicable
- Conditions
- Mild to Moderate Alzheimer Disease
- Interventions
- Device: TMSDevice: sham coil stimulation
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2020-02-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT04260724
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Driving Pressure and Postoperative Pulmonary Complications in Thoracic Surgery
Not Applicable
Completed
- Conditions
- Postoperative Pulmonary ComplicationOne-Lung VentilationThoracic SurgeryPostoperative ComplicationsDriving PressurePositive End Expiratory Pressure
- Interventions
- Other: ventilation
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1300
- Registration Number
- NCT04260451
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Effect of Intensive Nutritional Support in Subacute Stroke Patient
Not Applicable
Completed
- Conditions
- StrokeRehabilitationNutrition
- Interventions
- Drug: Omapone Peri 724mL or Winuf Peri 654mL
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 97
- Registration Number
- NCT04259307
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT04258072
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Ventilator-driven Alveolar Recruitment Maneuver
Not Applicable
Completed
- Conditions
- Ventilator LungPostoperative AtelectasisAtelectasisRecruitment
- Interventions
- Other: Alveolar recruitment maneuver
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-11-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 64
- Registration Number
- NCT04258202
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Genetic Characteristics of Metastatic Breast Cancer Patients
Not Applicable
- Conditions
- Metastatic Breast Cancer
- Interventions
- Diagnostic Test: Genomic analysis
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04258735
- Locations
- 🇰🇷
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
Completed
- Conditions
- Lung CancerDiagnoses Disease
- Interventions
- Diagnostic Test: Circulating Tumor DNA Methylation Sequencing
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 280
- Registration Number
- NCT04253509
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 93
- Registration Number
- NCT04249739
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath